MolecuLight Press Releases
PRESS RELEASE
In new publication, 96% of clinicians state that treatment plans informed using the MolecuLight...
PRESS RELEASE
MolecuLight Signs LMT Surgical as New Distributor for Australia and New Zealand
PRESS RELEASE
Novel Technology to Help Improve Wound Care in Canada Enabled Through CAN Health, Sunnybrook...
PRESS RELEASE
MolecuLight Receives Innovative Technology Contract from Vizient for its i:X®...
PRESS RELEASE
MolecuLight i:X® Platform Available to 650 Long-Term Healthcare Facilities...
PRESS RELEASE
Results Published in Study Show MolecuLight Fluorescence Point-of-Care Imaging Detected Pseudomonas...
Archive
2020
— PRESS RELEASE
Results Published from 2-Year Study of 229 Wounds Treated in an NHS Clinic Show Fluorescence Point-of-Care Imaging Improved Wound Healing Rates by 23%
— PRESS RELEASEResults from 350-Patient FLAAG Trial Show MolecuLight Point-of-Care Imaging Improves Detection of High Bacterial Burden in Wounds Four-fold over Standard of Care Assessment
— PRESS RELEASEMolecuLight Announces Availability of its MolecuLight i:X® Platform on Epic’s App Orchard
— PRESS RELEASELatest Clinical Evidence Presented at SAWC 2020 Illustrates the Significant Utility of the MolecuLight i:X® for Visualizing Bacteria and Improving Clinical Outcomes
— PRESS RELEASEMolecuLight Launches the i:X® Telemedicine Solution for Imaging of Bacteria in Wounds
— PRESS RELEASEMolecuLight Launches i:X® Sterile Surgical Sleeve for Imaging of Bacteria in Wounds in a Surgical Setting
— PRESS RELEASEMolecuLight i:X® Platform Available to 9,000 Healthcare Facilities Through MAGNET GROUP GPO
— PRESS RELEASEMolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X® Procedure for Bacterial Imaging using Fluorescence
— PRESS RELEASEMolecuLight Announces Industry Partnership and Virtual Exhibit of its MolecuLight i:X® Platform at WoundCon™ 2020, the Largest Conference for Wound Care
— PRESS RELEASEFirst Published Study to Report In Vitro Detection of Fluorescence from Bacteria in Biofilm with Point-of-care Wound Imaging Device
— PRESS RELEASENew MolecuLight i:X® Upgrade Enables Faster, More Accurate Digital Wound Measurement
— PRESS RELEASESDVOSB Maness Veteran Medical Partners with MolecuLight to Distribute its i:X® Real-Time Fluorescence Wound Imaging Platform to the US Department of Defence (DoD) and Veterans Affairs (VA)
— PRESS RELEASEAmerican Medical Association Issues Category lll CPT Codes for Real-time Fluorescence Wound Imaging
— PRESS RELEASEUniversity Hospitals Ahuja Medical Center Physician First in Ohio to Use Wound Care Imaging Device in Clinical Setting
2019
— PRESS RELEASE
MolecuLight Receives FDA 510(k) Clearance for its i:X® Handheld Fluorescence Imaging Device for Wound Management
— PRESS RELEASEAMA Announces Approval for Category lll CPT Code for Real-time Fluorescence Wound Imaging
— PRESS RELEASEClinical Results from the MolecuLight i:X® Fluorescence Imaging System are Featured in Two Clinical Talks and Seven Posters at the SAWC Fall 2019 Annual Conference
— PRESS RELEASEResults from Clinical Studies using MolecuLight i:X® Fluorescence Imaging System Featured Prominently at the Wounds Canada 2019 Annual Conference
— PRESS RELEASEPublished Study Finds 9/10 Chronic Wound Patients Likely to Have Received More Appropriately Triaged Care with Information from the MolecuLight i:X® Imaging Device
— PRESS RELEASEOxford Finance LLC Provides $7.5M USD Term Loan to MolecuLight®Inc. to Support Global Commercial Expansion
— PRESS RELEASEphotonamic GmbH & Co. KG (Germany) Acquires the Oncology Business from MolecuLight® Inc. (Canada)
2018
— PRESS RELEASE
MolecuLight® Inc.’s first-of-its-kind handheld fluorescence imaging device receives FDA De Novo clearance for US wound care market
— NEWSMolecuLight partners with SerenaGroup for a multi-center clinical trial
— NEWSMolecuLight clinical insights from EWMA 2018
— NEWSNew Publication: Efficacy of an imaging device at identifying the presence of bacteria in wounds at a plastic surgery outpatients clinic
2017
— BLOG
The role of the MolecuLight i:X in potential improvement of current debridement practices
— PRESS RELEASEMolecuLight announces appointment of Anil Amlani as CEO
— BLOGPredicting the presence of pathogenic bacteria in wounds
— NEWSNew Publication: Predicting the presence of pathogenic bacteria in wounds
— BLOGFish skin for human wounds: Iceland’s pioneering treatment
— NEWSRose Raizman receives EWMA e-poster prize
— NEWSImproving antimicrobial stewardship practices with the MolecuLight i:X
— NEWSEWMA 2017 update
— NEWSHow will fluorescence imaging impact wound care?
— NEWSThe use of MolecuLight i:X in managing burns
— NEWSMolecuLight at SAWC Spring 2017
— NEWSMolecuLight i:X featured in the Toronto Star.
— NEWSMolecuLight i:X performs better than Levine method to maximize sampling of treatment-relevant pathogens in chronic wounds.
— NEWSThe MolecuLight i:X a novel solution in the ever-increasing battle against antibiotic resistance?
— BLOGAntibiotic resistance continues to be a real issue
2016
— BLOG
MolecuLight Inc. participates as a secret Santa in the Adopt-a-Senior program
— NEWSAnnual CAWC Conference in Niagara Falls
— PRESS RELEASEThe revolutionary MolecuLight i:X Wound Imaging Device receives CE Mark approval
— BLOGThe latest innovations in wound diagnostics
— NEWSMolecuLight exhibited at the 2016 WOCN Society & CAET Joint Conference
— PRESS RELEASEMolecuLight Inc. ranked in the top 6 at the 2016 Medical Design Excellence Awards
— NEWSMolecuLight exhibited at the 26th annual EWMA Conference in Bremen, Germany
— NEWSMolecuLight exhibited at 2016 SAWC Spring
— NEWSThe new era of point-of-care testing
2015
— BLOG
